Bangladesh launches domestic LSD vaccine campaign
Analysis based on 6 articles · First reported Sep 04, 2026 · Last updated Sep 04, 2026
The domestic production of LSD and Goatpox vaccines is expected to reduce Bangladesh's dependence on imported vaccines, lowering costs for farmers and improving livestock health, which could enhance agricultural productivity and export potential. This development may benefit local veterinary and biotechnology sectors and support rural economic growth.
On 4 September 2026, Bangladesh's Fisheries, Livestock, and Agriculture Minister Aminur Rashid inaugurated a vaccination campaign for locally developed Lumpy Skin Disease (LSD) and Goatpox vaccines at Raichu Eidgah field in Adarsha Sadar upazila, Cumilla. The vaccines were developed by the Bangladesh — Bangladesh Livestock Research Institute (BLRI). The campaign, supported by the Bangladesh — Department of Livestock Services (DLS), began with the administration of 2,000 doses of LSD vaccine and 100 doses of Goatpox vaccine. Bangladesh requires around 25 million doses of LSD vaccine annually and has previously relied on imports. The minister emphasized that domestic production will lower costs, increase availability, and improve livestock sector sustainability. He also advocated for cultivating a new high-protein grass variety developed by BLRI (about 18% protein) to reduce feed costs, and announced a government initiative to conserve and expand the Black Bengal goat breed, prioritizing women and youth entrepreneurs. The event was chaired by BLRI Director General Dr Shakila Faruq, with DLS Director General Md Shahzaman Khan as special guest.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard